The detection of fibrinogen (or FgDP)-protamine sulphate complex in vitro and in the circulating blood.
In order to clarify the pathophysiological significance of the fibrinogen (FgDP)-protamine complex, the interaction between fibrinogen and protamine sulphate was studied in vitro and in vivo. Using the electrophoretic technique, an attempt was made to determine whether the complex could be detected in vitro and in the circulating blood. From the present studies, it has been clarified in in vitro experiments that the slower mobility of two peaks on immunoelectrophoresis represented a complex of protamine sulphate and fibrinogen (FgDP). Furthermore, the peak of slower mobility on crossed immunoelectrophoresis appeared in the circulating blood of a rabbit receiving administration of excess protamine sulphate. That is, in vivo experiments showed that a complex of protamine sulphate and fibrinogen (FgDP) could be detected in the circulating blood.
D000818:Animals; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism*; D006801:Humans; D007123:Immunoelectrophoresis, Two-Dimensional; D066298:In Vitro Techniques; D010314:Partial Thromboplastin Time; D011479:Protamines / Q000009:adverse effects / Q000097:blood*; D011817:Rabbits; D013927:Thrombosis / Q000139:chemically induced
D005338:Fibrin Fibrinogen Degradation Products; D011479:Protamines; D005340:Fibrinogen